The US FDA has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating acute leukaemia with KMT2A translocation.

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

The U.S. Food and Drug Administration (FDA) recently granted CYB003 Breakthrough Therapy Designation, accelerating its review ...

Experts have discovered that salmonella has been depleting a key protein which the body’s own immune cells need to function.

Researchers at Northwestern Medicine Canning Thoracic Institute have uncovered a startling connection between COVID-19 infections and cancer regression, raising the possibility of using the virus's ...

The birth of your baby is supposed to be one of the most joyous moments of a new mom’s life, but for one in seven new mothers ...

In today's biotech news, Zepbound trial data, Regenxbio's Duchenne muscular dystrophy treatment, and Intellia's promising ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

Biden Allows Ukraine to Strike Russia With Long-Range U.S. Missiles President Biden for the first time authorized the use of a system known as ATACMS to help defend Ukraine’s forces in the Kursk ...

UNRWA, the main U.N. agency aiding Palestinians, said its drivers were forced to unload supplies at gunpoint, in what it called one of the worst such incidents of the war. By Hiba Yazbek The ...

The Kroger Co. is recalling Home Chef Asian Style Chicken Stir Fry because meal kits contain cooked chicken which was recalled because of contamination with Listeria monocytogenes. According to ...

Canadians will get child benefit cheques this week amid Canada Post strike Canadians will get child benefit cheques this week amid Canada Post strike Parents who are expecting child benefit ...